TARO NYSE
Taro Pharmaceutical Industries Ltd.
1W: +0.5%
1M: +1.1%
3M: +1.9%
1Y: +6.1%
3Y: -41.2%
5Y: -51.4%
$42.98
Last traded 2024-06-21 — delisted
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
📊 Key Metrics
TTM$629M
Revenue
+9.8% YoY
$54M
Net Income
+111.7% YoY
$74M
Free Cash Flow
+523.3% YoY
53.0%
Gross Margin
5.3%
Op. Margin
9.1%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE3.1%
ROA2.5%
ROIC1.5%
Valuation
P/E30.1
P/B0.9
EV/EBITDA11.6
Leverage
Debt/Equity0.00
Current Ratio3.61
Interest Cov.0.0x
Quality Scores
Piotroski F9/9
Altman Z3.45
Beneish M-2.85